These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 7607862)

  • 1. Restenosis after PTCA.
    Assali A; Beigel Y
    Isr J Med Sci; 1995 Jun; 31(6):377-81. PubMed ID: 7607862
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pathophysiology of restenosis following percutaneous transluminal coronary angioplasty].
    Holm AM; Haunsø S; Hansen PR
    Ugeskr Laeger; 1998 Feb; 160(9):1302-6. PubMed ID: 9495077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deposition of PG-M/versican is a major cause of human coronary restenosis after percutaneous transluminal coronary angioplasty.
    Matsuura R; Isaka N; Imanaka-Yoshida K; Yoshida T; Sakakura T; Nakano T
    J Pathol; 1996 Nov; 180(3):311-6. PubMed ID: 8958811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restenosis after percutaneous transluminal coronary angioplasty in patients with non-insulin-dependent diabetes mellitus (NIDDM).
    Asakura Y; Suzuki M; Nonogi H; Haze K; Sato A; Inada H; Okuda Y; Yamashita K; Harano Y
    J Cardiovasc Risk; 1998; 5(5-6):331-4. PubMed ID: 9920005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intracoronary brachytherapy against restenosis after percutaneous transluminal coronary angioplasty].
    Holm AM; Haunsø S; Hansen PR
    Ugeskr Laeger; 1999 Feb; 161(6):802. PubMed ID: 10028887
    [No Abstract]   [Full Text] [Related]  

  • 6. [Restenosis after percutaneous coronary angioplasty--cause, prevention strategies].
    Szyguła J; Puzio B; Poloński L
    Wiad Lek; 1998; 51(1-2):76-81. PubMed ID: 9608836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Restenosis after coronary angioplasty: 30 per 100 only...].
    Cherrier F; Danchin N
    Rev Prat; 1990 Jan; 40(2):137-9. PubMed ID: 2300770
    [No Abstract]   [Full Text] [Related]  

  • 8. [Preventive mechanisms and effects of pemirolast potassium on restenosis after percutaneous transluminal coronary angioplasty: serial coronary angiography and intravascular ultrasound studies].
    Yoshinuma M
    J Cardiol; 1999 Feb; 33(2):81-8. PubMed ID: 10087476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of polymorphonuclear leukocyte adhesion molecules and its clinical significance in patients treated with percutaneous transluminal coronary angioplasty.
    Inoue T; Sakai Y; Morooka S; Hayashi T; Takayanagi K; Takabatake Y
    J Am Coll Cardiol; 1996 Nov; 28(5):1127-33. PubMed ID: 8890805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Coronary restenosis. An unresolved problem of percutaneous transluminal coronary angioplasty].
    Iñíguez Romo A
    Rev Esp Cardiol; 1993; 46 Suppl 3():85-96. PubMed ID: 8303057
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of amlodipine on ischemia after percutaneous transluminal coronary angioplasty: secondary results of the Coronary Angioplasty Amlodipine Restenosis (CAPARES) Study.
    Jørgensen B; Thaulow E;
    Am Heart J; 2003 Jun; 145(6):1030-5. PubMed ID: 12796759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lesion-related factors associated with restenosis after percutaneous transluminal coronary angioplasty in the absence of patient-related factors].
    Sakai Y; Tomobuchi Y; Hashizume T; Imanishi T; Tomimoto S; Toyoda Y; Arita M; Hano T; Nishio I
    J Cardiol; 1997 Jan; 29(1):1-6. PubMed ID: 9023673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluvastatin for the prevention of restenosis after coronary balloon angioplasty: angiographic and methodological background of the fluvastatin angioplasty restenosis trial.
    Foley DP; Serruys PW
    Br J Clin Pract Suppl; 1996 Jan; 77A():40-53. PubMed ID: 8729590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of antibodies to heat-shock protein-65 with percutaneous transluminal coronary angioplasty and subsequent restenosis.
    Mukherjee M; De Benedictis C; Jewitt D; Kakkar VV
    Thromb Haemost; 1996 Feb; 75(2):258-60. PubMed ID: 8815572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of lumen size to restenosis after percutaneous transluminal coronary balloon angioplasty. Lovastatin Restenosis Trial Group.
    Waksman R; Kosinski AS; Klein L; Boccuzzi SJ; King SB; Ghazzal ZM; Weintraub WS
    Am J Cardiol; 1996 Jul; 78(2):221-4. PubMed ID: 8712148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental and early clinical experience with reviparin-sodium for prevention of restenosis after percutaneous transluminal coronary angioplasty.
    Preisack MB; Karsch KR
    Blood Coagul Fibrinolysis; 1993 Dec; 4 Suppl 1():S55-8; discussion S59-60. PubMed ID: 8180331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can an old drug prevent restenosis after PTCA?
    Harv Heart Lett; 1998 Apr; 8(8):4-6. PubMed ID: 9549435
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prediction of restenosis after percutaneous transluminal coronary angioplasty using coronary flow reserve. Kansai Doppler Guide Wire Study Group].
    Toda I; Teragaki M; Nishida Y; Kobayashi Y; Shimada K; Yoshiyama M; Akioka K; Takeuchi K; Yoshikawa J
    J Cardiol; 2000 Mar; 35(3):165-73. PubMed ID: 10808423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Restenosis after percutaneous transluminal coronary angioplasty and its prevention].
    Przewłocka-Kosmala M; Kosmala W
    Przegl Lek; 1999; 56(10):671-5. PubMed ID: 10695384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical, experimental and physiopathological aspects of restenosis after coronary angioplasty].
    Brami M; Côté G; Bonan R
    Arch Mal Coeur Vaiss; 1997 Mar; 90(3):385-91. PubMed ID: 9232077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.